At Fosun Health, cervical cancer diagnosis is not just about “finding cancer”—it is about answering three critical questions: How far has it spread? Can we save your uterus and fertility? What are the molecular targets? Our integrated pathway delivers answers within days:
We perform high-resolution colposcopy with acetic acid and Lugol’s iodine to visualize abnormal cervical epithelium. Targeted biopsy confirms histology, tumor grade, and the presence of lymphovascular invasion.
The most accurate tool for local staging. MRI reveals the tumor’s size, depth of stromal invasion, and spread to parametrium, vagina, bladder, or rectum—directly determining whether fertility-sparing surgery, radical hysterectomy, or chemoradiotherapy is appropriate.
Detects lymph node metastases (pelvic, para-aortic) and distant spread (lungs, liver, bones). Essential for staging and radiotherapy planning.
Using NGS (Next-Generation Sequencing), we analyze PD-L1, HER2, TMB, MSI/dMMR, NTRK fusions, and over 300 cancer-related genes. This determines your eligibility for immunotherapy (pembrolizumab for PD-L1+ or MSI-H tumors), HER2-targeted therapy, or clinical trials of novel ADCs and bispecific antibodies—ensuring your treatment is matched to your tumor’s unique biology.
